Statins used in the general population conferred a 20% risk reduction for colorectal cancer with a possibly larger impact in patients with inflammatory bowel disease, according to an analysis presented during ACG 2020 Virtual.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.
